Global Influenza Drugs and Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Influenza Drugs and Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Influenza Drugs and Vaccines industry chain, the market status of Hospital Pharmacy (Influenza Drugs, Influenza Vaccines), Retail Pharmacy (Influenza Drugs, Influenza Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Drugs and Vaccines.
Regionally, the report analyzes the Influenza Drugs and Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Drugs and Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Drugs and Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Drugs and Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Influenza Drugs, Influenza Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Drugs and Vaccines market.
Regional Analysis: The report involves examining the Influenza Drugs and Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Drugs and Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Drugs and Vaccines:
Company Analysis: Report covers individual Influenza Drugs and Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Drugs and Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Retail Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Influenza Drugs and Vaccines. It assesses the current state, advancements, and potential future developments in Influenza Drugs and Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Drugs and Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Drugs and Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Influenza Drugs and Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Drugs and Vaccines, with price, sales, revenue and global market share of Influenza Drugs and Vaccines from 2019 to 2024.
Chapter 3, the Influenza Drugs and Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Drugs and Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Influenza Drugs and Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Drugs and Vaccines.
Chapter 14 and 15, to describe Influenza Drugs and Vaccines sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Influenza Drugs and Vaccines industry chain, the market status of Hospital Pharmacy (Influenza Drugs, Influenza Vaccines), Retail Pharmacy (Influenza Drugs, Influenza Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Influenza Drugs and Vaccines.
Regionally, the report analyzes the Influenza Drugs and Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Influenza Drugs and Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Influenza Drugs and Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Influenza Drugs and Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Tons), revenue generated, and market share of different by Type (e.g., Influenza Drugs, Influenza Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Influenza Drugs and Vaccines market.
Regional Analysis: The report involves examining the Influenza Drugs and Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Influenza Drugs and Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Influenza Drugs and Vaccines:
Company Analysis: Report covers individual Influenza Drugs and Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Influenza Drugs and Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Retail Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Influenza Drugs and Vaccines. It assesses the current state, advancements, and potential future developments in Influenza Drugs and Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Influenza Drugs and Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Influenza Drugs and Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Influenza Drugs
- Influenza Vaccines
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- CSL
- Bristol Myers Squibb
- AstraZeneca
- Eli Lilly
- Roche
- GlaxoSmithKline
- Novartis
- Pfizer
- Sanofi
- Bayer
- Celgene
- Seqirus
- Protein Sciences Corporation
- Serum Institute of India
- Emergent Biosolutions
- BioCryst Pharmaceuticals
- Alvogen
- Viatris
- Hulan Bio
- Changchun Institute of Biological
- Jiangsu GDK
- Sinovac
- Beike Bio
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Influenza Drugs and Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Drugs and Vaccines, with price, sales, revenue and global market share of Influenza Drugs and Vaccines from 2019 to 2024.
Chapter 3, the Influenza Drugs and Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Drugs and Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Influenza Drugs and Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Drugs and Vaccines.
Chapter 14 and 15, to describe Influenza Drugs and Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Influenza Drugs and Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza Drugs and Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Influenza Drugs
1.3.3 Influenza Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza Drugs and Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Influenza Drugs and Vaccines Market Size & Forecast
1.5.1 Global Influenza Drugs and Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Influenza Drugs and Vaccines Sales Quantity (2019-2030)
1.5.3 Global Influenza Drugs and Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Influenza Drugs and Vaccines Product and Services
2.1.4 CSL Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CSL Recent Developments/Updates
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Product and Services
2.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol Myers Squibb Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Influenza Drugs and Vaccines Product and Services
2.3.4 AstraZeneca Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Influenza Drugs and Vaccines Product and Services
2.4.4 Eli Lilly Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly Recent Developments/Updates
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Influenza Drugs and Vaccines Product and Services
2.5.4 Roche Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments/Updates
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Product and Services
2.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments/Updates
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Influenza Drugs and Vaccines Product and Services
2.7.4 Novartis Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Novartis Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Influenza Drugs and Vaccines Product and Services
2.8.4 Pfizer Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Influenza Drugs and Vaccines Product and Services
2.9.4 Sanofi Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sanofi Recent Developments/Updates
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business
2.10.3 Bayer Influenza Drugs and Vaccines Product and Services
2.10.4 Bayer Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bayer Recent Developments/Updates
2.11 Celgene
2.11.1 Celgene Details
2.11.2 Celgene Major Business
2.11.3 Celgene Influenza Drugs and Vaccines Product and Services
2.11.4 Celgene Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Celgene Recent Developments/Updates
2.12 Seqirus
2.12.1 Seqirus Details
2.12.2 Seqirus Major Business
2.12.3 Seqirus Influenza Drugs and Vaccines Product and Services
2.12.4 Seqirus Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Seqirus Recent Developments/Updates
2.13 Protein Sciences Corporation
2.13.1 Protein Sciences Corporation Details
2.13.2 Protein Sciences Corporation Major Business
2.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Product and Services
2.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Protein Sciences Corporation Recent Developments/Updates
2.14 Serum Institute of India
2.14.1 Serum Institute of India Details
2.14.2 Serum Institute of India Major Business
2.14.3 Serum Institute of India Influenza Drugs and Vaccines Product and Services
2.14.4 Serum Institute of India Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Serum Institute of India Recent Developments/Updates
2.15 Emergent Biosolutions
2.15.1 Emergent Biosolutions Details
2.15.2 Emergent Biosolutions Major Business
2.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Product and Services
2.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Emergent Biosolutions Recent Developments/Updates
2.16 BioCryst Pharmaceuticals
2.16.1 BioCryst Pharmaceuticals Details
2.16.2 BioCryst Pharmaceuticals Major Business
2.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product and Services
2.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 BioCryst Pharmaceuticals Recent Developments/Updates
2.17 Alvogen
2.17.1 Alvogen Details
2.17.2 Alvogen Major Business
2.17.3 Alvogen Influenza Drugs and Vaccines Product and Services
2.17.4 Alvogen Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Alvogen Recent Developments/Updates
2.18 Viatris
2.18.1 Viatris Details
2.18.2 Viatris Major Business
2.18.3 Viatris Influenza Drugs and Vaccines Product and Services
2.18.4 Viatris Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Viatris Recent Developments/Updates
2.19 Hulan Bio
2.19.1 Hulan Bio Details
2.19.2 Hulan Bio Major Business
2.19.3 Hulan Bio Influenza Drugs and Vaccines Product and Services
2.19.4 Hulan Bio Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Hulan Bio Recent Developments/Updates
2.20 Changchun Institute of Biological
2.20.1 Changchun Institute of Biological Details
2.20.2 Changchun Institute of Biological Major Business
2.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Product and Services
2.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Changchun Institute of Biological Recent Developments/Updates
2.21 Jiangsu GDK
2.21.1 Jiangsu GDK Details
2.21.2 Jiangsu GDK Major Business
2.21.3 Jiangsu GDK Influenza Drugs and Vaccines Product and Services
2.21.4 Jiangsu GDK Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Jiangsu GDK Recent Developments/Updates
2.22 Sinovac
2.22.1 Sinovac Details
2.22.2 Sinovac Major Business
2.22.3 Sinovac Influenza Drugs and Vaccines Product and Services
2.22.4 Sinovac Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Sinovac Recent Developments/Updates
2.23 Beike Bio
2.23.1 Beike Bio Details
2.23.2 Beike Bio Major Business
2.23.3 Beike Bio Influenza Drugs and Vaccines Product and Services
2.23.4 Beike Bio Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Beike Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLUENZA DRUGS AND VACCINES BY MANUFACTURER
3.1 Global Influenza Drugs and Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Influenza Drugs and Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Influenza Drugs and Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Influenza Drugs and Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Influenza Drugs and Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Influenza Drugs and Vaccines Manufacturer Market Share in 2023
3.5 Influenza Drugs and Vaccines Market: Overall Company Footprint Analysis
3.5.1 Influenza Drugs and Vaccines Market: Region Footprint
3.5.2 Influenza Drugs and Vaccines Market: Company Product Type Footprint
3.5.3 Influenza Drugs and Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Influenza Drugs and Vaccines Market Size by Region
4.1.1 Global Influenza Drugs and Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Influenza Drugs and Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Influenza Drugs and Vaccines Average Price by Region (2019-2030)
4.2 North America Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.3 Europe Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.5 South America Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Influenza Drugs and Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Influenza Drugs and Vaccines Consumption Value by Type (2019-2030)
5.3 Global Influenza Drugs and Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Influenza Drugs and Vaccines Consumption Value by Application (2019-2030)
6.3 Global Influenza Drugs and Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Influenza Drugs and Vaccines Market Size by Country
7.3.1 North America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Influenza Drugs and Vaccines Market Size by Country
8.3.1 Europe Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Influenza Drugs and Vaccines Market Size by Region
9.3.1 Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Influenza Drugs and Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Influenza Drugs and Vaccines Market Size by Country
10.3.1 South America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Influenza Drugs and Vaccines Market Size by Country
11.3.1 Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Influenza Drugs and Vaccines Market Drivers
12.2 Influenza Drugs and Vaccines Market Restraints
12.3 Influenza Drugs and Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Influenza Drugs and Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza Drugs and Vaccines
13.3 Influenza Drugs and Vaccines Production Process
13.4 Influenza Drugs and Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza Drugs and Vaccines Typical Distributors
14.3 Influenza Drugs and Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Influenza Drugs and Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza Drugs and Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Influenza Drugs
1.3.3 Influenza Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza Drugs and Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Influenza Drugs and Vaccines Market Size & Forecast
1.5.1 Global Influenza Drugs and Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Influenza Drugs and Vaccines Sales Quantity (2019-2030)
1.5.3 Global Influenza Drugs and Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Influenza Drugs and Vaccines Product and Services
2.1.4 CSL Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CSL Recent Developments/Updates
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Product and Services
2.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol Myers Squibb Recent Developments/Updates
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Influenza Drugs and Vaccines Product and Services
2.3.4 AstraZeneca Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 AstraZeneca Recent Developments/Updates
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Influenza Drugs and Vaccines Product and Services
2.4.4 Eli Lilly Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly Recent Developments/Updates
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Influenza Drugs and Vaccines Product and Services
2.5.4 Roche Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments/Updates
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Product and Services
2.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments/Updates
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Influenza Drugs and Vaccines Product and Services
2.7.4 Novartis Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Novartis Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Influenza Drugs and Vaccines Product and Services
2.8.4 Pfizer Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Influenza Drugs and Vaccines Product and Services
2.9.4 Sanofi Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sanofi Recent Developments/Updates
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business
2.10.3 Bayer Influenza Drugs and Vaccines Product and Services
2.10.4 Bayer Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bayer Recent Developments/Updates
2.11 Celgene
2.11.1 Celgene Details
2.11.2 Celgene Major Business
2.11.3 Celgene Influenza Drugs and Vaccines Product and Services
2.11.4 Celgene Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Celgene Recent Developments/Updates
2.12 Seqirus
2.12.1 Seqirus Details
2.12.2 Seqirus Major Business
2.12.3 Seqirus Influenza Drugs and Vaccines Product and Services
2.12.4 Seqirus Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Seqirus Recent Developments/Updates
2.13 Protein Sciences Corporation
2.13.1 Protein Sciences Corporation Details
2.13.2 Protein Sciences Corporation Major Business
2.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Product and Services
2.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Protein Sciences Corporation Recent Developments/Updates
2.14 Serum Institute of India
2.14.1 Serum Institute of India Details
2.14.2 Serum Institute of India Major Business
2.14.3 Serum Institute of India Influenza Drugs and Vaccines Product and Services
2.14.4 Serum Institute of India Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Serum Institute of India Recent Developments/Updates
2.15 Emergent Biosolutions
2.15.1 Emergent Biosolutions Details
2.15.2 Emergent Biosolutions Major Business
2.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Product and Services
2.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Emergent Biosolutions Recent Developments/Updates
2.16 BioCryst Pharmaceuticals
2.16.1 BioCryst Pharmaceuticals Details
2.16.2 BioCryst Pharmaceuticals Major Business
2.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product and Services
2.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 BioCryst Pharmaceuticals Recent Developments/Updates
2.17 Alvogen
2.17.1 Alvogen Details
2.17.2 Alvogen Major Business
2.17.3 Alvogen Influenza Drugs and Vaccines Product and Services
2.17.4 Alvogen Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Alvogen Recent Developments/Updates
2.18 Viatris
2.18.1 Viatris Details
2.18.2 Viatris Major Business
2.18.3 Viatris Influenza Drugs and Vaccines Product and Services
2.18.4 Viatris Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Viatris Recent Developments/Updates
2.19 Hulan Bio
2.19.1 Hulan Bio Details
2.19.2 Hulan Bio Major Business
2.19.3 Hulan Bio Influenza Drugs and Vaccines Product and Services
2.19.4 Hulan Bio Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Hulan Bio Recent Developments/Updates
2.20 Changchun Institute of Biological
2.20.1 Changchun Institute of Biological Details
2.20.2 Changchun Institute of Biological Major Business
2.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Product and Services
2.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Changchun Institute of Biological Recent Developments/Updates
2.21 Jiangsu GDK
2.21.1 Jiangsu GDK Details
2.21.2 Jiangsu GDK Major Business
2.21.3 Jiangsu GDK Influenza Drugs and Vaccines Product and Services
2.21.4 Jiangsu GDK Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Jiangsu GDK Recent Developments/Updates
2.22 Sinovac
2.22.1 Sinovac Details
2.22.2 Sinovac Major Business
2.22.3 Sinovac Influenza Drugs and Vaccines Product and Services
2.22.4 Sinovac Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Sinovac Recent Developments/Updates
2.23 Beike Bio
2.23.1 Beike Bio Details
2.23.2 Beike Bio Major Business
2.23.3 Beike Bio Influenza Drugs and Vaccines Product and Services
2.23.4 Beike Bio Influenza Drugs and Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Beike Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLUENZA DRUGS AND VACCINES BY MANUFACTURER
3.1 Global Influenza Drugs and Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Influenza Drugs and Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Influenza Drugs and Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Influenza Drugs and Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Influenza Drugs and Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Influenza Drugs and Vaccines Manufacturer Market Share in 2023
3.5 Influenza Drugs and Vaccines Market: Overall Company Footprint Analysis
3.5.1 Influenza Drugs and Vaccines Market: Region Footprint
3.5.2 Influenza Drugs and Vaccines Market: Company Product Type Footprint
3.5.3 Influenza Drugs and Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Influenza Drugs and Vaccines Market Size by Region
4.1.1 Global Influenza Drugs and Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Influenza Drugs and Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Influenza Drugs and Vaccines Average Price by Region (2019-2030)
4.2 North America Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.3 Europe Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.5 South America Influenza Drugs and Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Influenza Drugs and Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Influenza Drugs and Vaccines Consumption Value by Type (2019-2030)
5.3 Global Influenza Drugs and Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Influenza Drugs and Vaccines Consumption Value by Application (2019-2030)
6.3 Global Influenza Drugs and Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Influenza Drugs and Vaccines Market Size by Country
7.3.1 North America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Influenza Drugs and Vaccines Market Size by Country
8.3.1 Europe Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Influenza Drugs and Vaccines Market Size by Region
9.3.1 Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Influenza Drugs and Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Influenza Drugs and Vaccines Market Size by Country
10.3.1 South America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Influenza Drugs and Vaccines Market Size by Country
11.3.1 Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Influenza Drugs and Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Influenza Drugs and Vaccines Market Drivers
12.2 Influenza Drugs and Vaccines Market Restraints
12.3 Influenza Drugs and Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Influenza Drugs and Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza Drugs and Vaccines
13.3 Influenza Drugs and Vaccines Production Process
13.4 Influenza Drugs and Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza Drugs and Vaccines Typical Distributors
14.3 Influenza Drugs and Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Influenza Drugs and Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Drugs and Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Influenza Drugs and Vaccines Product and Services
Table 6. CSL Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CSL Recent Developments/Updates
Table 8. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 9. Bristol Myers Squibb Major Business
Table 10. Bristol Myers Squibb Influenza Drugs and Vaccines Product and Services
Table 11. Bristol Myers Squibb Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bristol Myers Squibb Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca Influenza Drugs and Vaccines Product and Services
Table 16. AstraZeneca Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly Influenza Drugs and Vaccines Product and Services
Table 21. Eli Lilly Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Eli Lilly Recent Developments/Updates
Table 23. Roche Basic Information, Manufacturing Base and Competitors
Table 24. Roche Major Business
Table 25. Roche Influenza Drugs and Vaccines Product and Services
Table 26. Roche Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Roche Recent Developments/Updates
Table 28. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Major Business
Table 30. GlaxoSmithKline Influenza Drugs and Vaccines Product and Services
Table 31. GlaxoSmithKline Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. GlaxoSmithKline Recent Developments/Updates
Table 33. Novartis Basic Information, Manufacturing Base and Competitors
Table 34. Novartis Major Business
Table 35. Novartis Influenza Drugs and Vaccines Product and Services
Table 36. Novartis Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Novartis Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Influenza Drugs and Vaccines Product and Services
Table 41. Pfizer Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Pfizer Recent Developments/Updates
Table 43. Sanofi Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Major Business
Table 45. Sanofi Influenza Drugs and Vaccines Product and Services
Table 46. Sanofi Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Sanofi Recent Developments/Updates
Table 48. Bayer Basic Information, Manufacturing Base and Competitors
Table 49. Bayer Major Business
Table 50. Bayer Influenza Drugs and Vaccines Product and Services
Table 51. Bayer Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Bayer Recent Developments/Updates
Table 53. Celgene Basic Information, Manufacturing Base and Competitors
Table 54. Celgene Major Business
Table 55. Celgene Influenza Drugs and Vaccines Product and Services
Table 56. Celgene Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Celgene Recent Developments/Updates
Table 58. Seqirus Basic Information, Manufacturing Base and Competitors
Table 59. Seqirus Major Business
Table 60. Seqirus Influenza Drugs and Vaccines Product and Services
Table 61. Seqirus Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Seqirus Recent Developments/Updates
Table 63. Protein Sciences Corporation Basic Information, Manufacturing Base and Competitors
Table 64. Protein Sciences Corporation Major Business
Table 65. Protein Sciences Corporation Influenza Drugs and Vaccines Product and Services
Table 66. Protein Sciences Corporation Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Protein Sciences Corporation Recent Developments/Updates
Table 68. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 69. Serum Institute of India Major Business
Table 70. Serum Institute of India Influenza Drugs and Vaccines Product and Services
Table 71. Serum Institute of India Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Serum Institute of India Recent Developments/Updates
Table 73. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 74. Emergent Biosolutions Major Business
Table 75. Emergent Biosolutions Influenza Drugs and Vaccines Product and Services
Table 76. Emergent Biosolutions Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Emergent Biosolutions Recent Developments/Updates
Table 78. BioCryst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. BioCryst Pharmaceuticals Major Business
Table 80. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product and Services
Table 81. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. BioCryst Pharmaceuticals Recent Developments/Updates
Table 83. Alvogen Basic Information, Manufacturing Base and Competitors
Table 84. Alvogen Major Business
Table 85. Alvogen Influenza Drugs and Vaccines Product and Services
Table 86. Alvogen Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Alvogen Recent Developments/Updates
Table 88. Viatris Basic Information, Manufacturing Base and Competitors
Table 89. Viatris Major Business
Table 90. Viatris Influenza Drugs and Vaccines Product and Services
Table 91. Viatris Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Viatris Recent Developments/Updates
Table 93. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 94. Hulan Bio Major Business
Table 95. Hulan Bio Influenza Drugs and Vaccines Product and Services
Table 96. Hulan Bio Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Hulan Bio Recent Developments/Updates
Table 98. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 99. Changchun Institute of Biological Major Business
Table 100. Changchun Institute of Biological Influenza Drugs and Vaccines Product and Services
Table 101. Changchun Institute of Biological Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Changchun Institute of Biological Recent Developments/Updates
Table 103. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 104. Jiangsu GDK Major Business
Table 105. Jiangsu GDK Influenza Drugs and Vaccines Product and Services
Table 106. Jiangsu GDK Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Jiangsu GDK Recent Developments/Updates
Table 108. Sinovac Basic Information, Manufacturing Base and Competitors
Table 109. Sinovac Major Business
Table 110. Sinovac Influenza Drugs and Vaccines Product and Services
Table 111. Sinovac Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Sinovac Recent Developments/Updates
Table 113. Beike Bio Basic Information, Manufacturing Base and Competitors
Table 114. Beike Bio Major Business
Table 115. Beike Bio Influenza Drugs and Vaccines Product and Services
Table 116. Beike Bio Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 117. Beike Bio Recent Developments/Updates
Table 118. Global Influenza Drugs and Vaccines Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 119. Global Influenza Drugs and Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 120. Global Influenza Drugs and Vaccines Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 121. Market Position of Manufacturers in Influenza Drugs and Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 122. Head Office and Influenza Drugs and Vaccines Production Site of Key Manufacturer
Table 123. Influenza Drugs and Vaccines Market: Company Product Type Footprint
Table 124. Influenza Drugs and Vaccines Market: Company Product Application Footprint
Table 125. Influenza Drugs and Vaccines New Market Entrants and Barriers to Market Entry
Table 126. Influenza Drugs and Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 127. Global Influenza Drugs and Vaccines Sales Quantity by Region (2019-2024) & (Tons)
Table 128. Global Influenza Drugs and Vaccines Sales Quantity by Region (2025-2030) & (Tons)
Table 129. Global Influenza Drugs and Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 130. Global Influenza Drugs and Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 131. Global Influenza Drugs and Vaccines Average Price by Region (2019-2024) & (US$/Kg)
Table 132. Global Influenza Drugs and Vaccines Average Price by Region (2025-2030) & (US$/Kg)
Table 133. Global Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 134. Global Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 135. Global Influenza Drugs and Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Global Influenza Drugs and Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Global Influenza Drugs and Vaccines Average Price by Type (2019-2024) & (US$/Kg)
Table 138. Global Influenza Drugs and Vaccines Average Price by Type (2025-2030) & (US$/Kg)
Table 139. Global Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 140. Global Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 141. Global Influenza Drugs and Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 142. Global Influenza Drugs and Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 143. Global Influenza Drugs and Vaccines Average Price by Application (2019-2024) & (US$/Kg)
Table 144. Global Influenza Drugs and Vaccines Average Price by Application (2025-2030) & (US$/Kg)
Table 145. North America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 146. North America Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 147. North America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 148. North America Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 149. North America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2024) & (Tons)
Table 150. North America Influenza Drugs and Vaccines Sales Quantity by Country (2025-2030) & (Tons)
Table 151. North America Influenza Drugs and Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 152. North America Influenza Drugs and Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Europe Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 154. Europe Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 155. Europe Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 156. Europe Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 157. Europe Influenza Drugs and Vaccines Sales Quantity by Country (2019-2024) & (Tons)
Table 158. Europe Influenza Drugs and Vaccines Sales Quantity by Country (2025-2030) & (Tons)
Table 159. Europe Influenza Drugs and Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 160. Europe Influenza Drugs and Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 161. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 162. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 163. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 164. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 165. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Region (2019-2024) & (Tons)
Table 166. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Region (2025-2030) & (Tons)
Table 167. Asia-Pacific Influenza Drugs and Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 168. Asia-Pacific Influenza Drugs and Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 169. South America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 170. South America Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 171. South America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 172. South America Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 173. South America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2024) & (Tons)
Table 174. South America Influenza Drugs and Vaccines Sales Quantity by Country (2025-2030) & (Tons)
Table 175. South America Influenza Drugs and Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 176. South America Influenza Drugs and Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 177. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 178. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 179. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 180. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 181. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Region (2019-2024) & (Tons)
Table 182. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Region (2025-2030) & (Tons)
Table 183. Middle East & Africa Influenza Drugs and Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 184. Middle East & Africa Influenza Drugs and Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 185. Influenza Drugs and Vaccines Raw Material
Table 186. Key Manufacturers of Influenza Drugs and Vaccines Raw Materials
Table 187. Influenza Drugs and Vaccines Typical Distributors
Table 188. Influenza Drugs and Vaccines Typical Customers
Table 1. Global Influenza Drugs and Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Drugs and Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Influenza Drugs and Vaccines Product and Services
Table 6. CSL Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CSL Recent Developments/Updates
Table 8. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 9. Bristol Myers Squibb Major Business
Table 10. Bristol Myers Squibb Influenza Drugs and Vaccines Product and Services
Table 11. Bristol Myers Squibb Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bristol Myers Squibb Recent Developments/Updates
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Major Business
Table 15. AstraZeneca Influenza Drugs and Vaccines Product and Services
Table 16. AstraZeneca Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. AstraZeneca Recent Developments/Updates
Table 18. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly Influenza Drugs and Vaccines Product and Services
Table 21. Eli Lilly Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Eli Lilly Recent Developments/Updates
Table 23. Roche Basic Information, Manufacturing Base and Competitors
Table 24. Roche Major Business
Table 25. Roche Influenza Drugs and Vaccines Product and Services
Table 26. Roche Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Roche Recent Developments/Updates
Table 28. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Major Business
Table 30. GlaxoSmithKline Influenza Drugs and Vaccines Product and Services
Table 31. GlaxoSmithKline Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. GlaxoSmithKline Recent Developments/Updates
Table 33. Novartis Basic Information, Manufacturing Base and Competitors
Table 34. Novartis Major Business
Table 35. Novartis Influenza Drugs and Vaccines Product and Services
Table 36. Novartis Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Novartis Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Influenza Drugs and Vaccines Product and Services
Table 41. Pfizer Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Pfizer Recent Developments/Updates
Table 43. Sanofi Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Major Business
Table 45. Sanofi Influenza Drugs and Vaccines Product and Services
Table 46. Sanofi Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Sanofi Recent Developments/Updates
Table 48. Bayer Basic Information, Manufacturing Base and Competitors
Table 49. Bayer Major Business
Table 50. Bayer Influenza Drugs and Vaccines Product and Services
Table 51. Bayer Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Bayer Recent Developments/Updates
Table 53. Celgene Basic Information, Manufacturing Base and Competitors
Table 54. Celgene Major Business
Table 55. Celgene Influenza Drugs and Vaccines Product and Services
Table 56. Celgene Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Celgene Recent Developments/Updates
Table 58. Seqirus Basic Information, Manufacturing Base and Competitors
Table 59. Seqirus Major Business
Table 60. Seqirus Influenza Drugs and Vaccines Product and Services
Table 61. Seqirus Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Seqirus Recent Developments/Updates
Table 63. Protein Sciences Corporation Basic Information, Manufacturing Base and Competitors
Table 64. Protein Sciences Corporation Major Business
Table 65. Protein Sciences Corporation Influenza Drugs and Vaccines Product and Services
Table 66. Protein Sciences Corporation Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Protein Sciences Corporation Recent Developments/Updates
Table 68. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 69. Serum Institute of India Major Business
Table 70. Serum Institute of India Influenza Drugs and Vaccines Product and Services
Table 71. Serum Institute of India Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Serum Institute of India Recent Developments/Updates
Table 73. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 74. Emergent Biosolutions Major Business
Table 75. Emergent Biosolutions Influenza Drugs and Vaccines Product and Services
Table 76. Emergent Biosolutions Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Emergent Biosolutions Recent Developments/Updates
Table 78. BioCryst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. BioCryst Pharmaceuticals Major Business
Table 80. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product and Services
Table 81. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. BioCryst Pharmaceuticals Recent Developments/Updates
Table 83. Alvogen Basic Information, Manufacturing Base and Competitors
Table 84. Alvogen Major Business
Table 85. Alvogen Influenza Drugs and Vaccines Product and Services
Table 86. Alvogen Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Alvogen Recent Developments/Updates
Table 88. Viatris Basic Information, Manufacturing Base and Competitors
Table 89. Viatris Major Business
Table 90. Viatris Influenza Drugs and Vaccines Product and Services
Table 91. Viatris Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Viatris Recent Developments/Updates
Table 93. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 94. Hulan Bio Major Business
Table 95. Hulan Bio Influenza Drugs and Vaccines Product and Services
Table 96. Hulan Bio Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Hulan Bio Recent Developments/Updates
Table 98. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
Table 99. Changchun Institute of Biological Major Business
Table 100. Changchun Institute of Biological Influenza Drugs and Vaccines Product and Services
Table 101. Changchun Institute of Biological Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Changchun Institute of Biological Recent Developments/Updates
Table 103. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
Table 104. Jiangsu GDK Major Business
Table 105. Jiangsu GDK Influenza Drugs and Vaccines Product and Services
Table 106. Jiangsu GDK Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Jiangsu GDK Recent Developments/Updates
Table 108. Sinovac Basic Information, Manufacturing Base and Competitors
Table 109. Sinovac Major Business
Table 110. Sinovac Influenza Drugs and Vaccines Product and Services
Table 111. Sinovac Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Sinovac Recent Developments/Updates
Table 113. Beike Bio Basic Information, Manufacturing Base and Competitors
Table 114. Beike Bio Major Business
Table 115. Beike Bio Influenza Drugs and Vaccines Product and Services
Table 116. Beike Bio Influenza Drugs and Vaccines Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 117. Beike Bio Recent Developments/Updates
Table 118. Global Influenza Drugs and Vaccines Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 119. Global Influenza Drugs and Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 120. Global Influenza Drugs and Vaccines Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 121. Market Position of Manufacturers in Influenza Drugs and Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 122. Head Office and Influenza Drugs and Vaccines Production Site of Key Manufacturer
Table 123. Influenza Drugs and Vaccines Market: Company Product Type Footprint
Table 124. Influenza Drugs and Vaccines Market: Company Product Application Footprint
Table 125. Influenza Drugs and Vaccines New Market Entrants and Barriers to Market Entry
Table 126. Influenza Drugs and Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 127. Global Influenza Drugs and Vaccines Sales Quantity by Region (2019-2024) & (Tons)
Table 128. Global Influenza Drugs and Vaccines Sales Quantity by Region (2025-2030) & (Tons)
Table 129. Global Influenza Drugs and Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 130. Global Influenza Drugs and Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 131. Global Influenza Drugs and Vaccines Average Price by Region (2019-2024) & (US$/Kg)
Table 132. Global Influenza Drugs and Vaccines Average Price by Region (2025-2030) & (US$/Kg)
Table 133. Global Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 134. Global Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 135. Global Influenza Drugs and Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 136. Global Influenza Drugs and Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 137. Global Influenza Drugs and Vaccines Average Price by Type (2019-2024) & (US$/Kg)
Table 138. Global Influenza Drugs and Vaccines Average Price by Type (2025-2030) & (US$/Kg)
Table 139. Global Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 140. Global Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 141. Global Influenza Drugs and Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 142. Global Influenza Drugs and Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 143. Global Influenza Drugs and Vaccines Average Price by Application (2019-2024) & (US$/Kg)
Table 144. Global Influenza Drugs and Vaccines Average Price by Application (2025-2030) & (US$/Kg)
Table 145. North America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 146. North America Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 147. North America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 148. North America Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 149. North America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2024) & (Tons)
Table 150. North America Influenza Drugs and Vaccines Sales Quantity by Country (2025-2030) & (Tons)
Table 151. North America Influenza Drugs and Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 152. North America Influenza Drugs and Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 153. Europe Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 154. Europe Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 155. Europe Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 156. Europe Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 157. Europe Influenza Drugs and Vaccines Sales Quantity by Country (2019-2024) & (Tons)
Table 158. Europe Influenza Drugs and Vaccines Sales Quantity by Country (2025-2030) & (Tons)
Table 159. Europe Influenza Drugs and Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 160. Europe Influenza Drugs and Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 161. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 162. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 163. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 164. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 165. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Region (2019-2024) & (Tons)
Table 166. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity by Region (2025-2030) & (Tons)
Table 167. Asia-Pacific Influenza Drugs and Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 168. Asia-Pacific Influenza Drugs and Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 169. South America Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 170. South America Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 171. South America Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 172. South America Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 173. South America Influenza Drugs and Vaccines Sales Quantity by Country (2019-2024) & (Tons)
Table 174. South America Influenza Drugs and Vaccines Sales Quantity by Country (2025-2030) & (Tons)
Table 175. South America Influenza Drugs and Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 176. South America Influenza Drugs and Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 177. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Type (2019-2024) & (Tons)
Table 178. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Type (2025-2030) & (Tons)
Table 179. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Application (2019-2024) & (Tons)
Table 180. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Application (2025-2030) & (Tons)
Table 181. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Region (2019-2024) & (Tons)
Table 182. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity by Region (2025-2030) & (Tons)
Table 183. Middle East & Africa Influenza Drugs and Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 184. Middle East & Africa Influenza Drugs and Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 185. Influenza Drugs and Vaccines Raw Material
Table 186. Key Manufacturers of Influenza Drugs and Vaccines Raw Materials
Table 187. Influenza Drugs and Vaccines Typical Distributors
Table 188. Influenza Drugs and Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Influenza Drugs and Vaccines Picture
Figure 2. Global Influenza Drugs and Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Drugs and Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Influenza Drugs Examples
Figure 5. Influenza Vaccines Examples
Figure 6. Global Influenza Drugs and Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Influenza Drugs and Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Hospital Pharmacy Examples
Figure 9. Retail Pharmacy Examples
Figure 10. Online Pharmacy Examples
Figure 11. Global Influenza Drugs and Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Drugs and Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Influenza Drugs and Vaccines Sales Quantity (2019-2030) & (Tons)
Figure 14. Global Influenza Drugs and Vaccines Average Price (2019-2030) & (US$/Kg)
Figure 15. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Influenza Drugs and Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Influenza Drugs and Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Influenza Drugs and Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Influenza Drugs and Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Influenza Drugs and Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Influenza Drugs and Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Influenza Drugs and Vaccines Average Price by Type (2019-2030) & (US$/Kg)
Figure 30. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Influenza Drugs and Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Influenza Drugs and Vaccines Average Price by Application (2019-2030) & (US$/Kg)
Figure 33. North America Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Influenza Drugs and Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Influenza Drugs and Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Influenza Drugs and Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Influenza Drugs and Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Influenza Drugs and Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 53. China Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Influenza Drugs and Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Influenza Drugs and Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Influenza Drugs and Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Influenza Drugs and Vaccines Market Drivers
Figure 74. Influenza Drugs and Vaccines Market Restraints
Figure 75. Influenza Drugs and Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Influenza Drugs and Vaccines in 2023
Figure 78. Manufacturing Process Analysis of Influenza Drugs and Vaccines
Figure 79. Influenza Drugs and Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Influenza Drugs and Vaccines Picture
Figure 2. Global Influenza Drugs and Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Drugs and Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Influenza Drugs Examples
Figure 5. Influenza Vaccines Examples
Figure 6. Global Influenza Drugs and Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Influenza Drugs and Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Hospital Pharmacy Examples
Figure 9. Retail Pharmacy Examples
Figure 10. Online Pharmacy Examples
Figure 11. Global Influenza Drugs and Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Drugs and Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Influenza Drugs and Vaccines Sales Quantity (2019-2030) & (Tons)
Figure 14. Global Influenza Drugs and Vaccines Average Price (2019-2030) & (US$/Kg)
Figure 15. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Influenza Drugs and Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Influenza Drugs and Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Influenza Drugs and Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Influenza Drugs and Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Influenza Drugs and Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Influenza Drugs and Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Influenza Drugs and Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Influenza Drugs and Vaccines Average Price by Type (2019-2030) & (US$/Kg)
Figure 30. Global Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Influenza Drugs and Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Influenza Drugs and Vaccines Average Price by Application (2019-2030) & (US$/Kg)
Figure 33. North America Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Influenza Drugs and Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Influenza Drugs and Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Influenza Drugs and Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Influenza Drugs and Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Influenza Drugs and Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Influenza Drugs and Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 53. China Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Influenza Drugs and Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Influenza Drugs and Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Influenza Drugs and Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Influenza Drugs and Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Influenza Drugs and Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Influenza Drugs and Vaccines Market Drivers
Figure 74. Influenza Drugs and Vaccines Market Restraints
Figure 75. Influenza Drugs and Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Influenza Drugs and Vaccines in 2023
Figure 78. Manufacturing Process Analysis of Influenza Drugs and Vaccines
Figure 79. Influenza Drugs and Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
